Quick filters
35 Matches
1
2
- Exelixis Announces Webcasts of Upcoming Investor Conference Presentations in November Business Wire | Monday November 5, 2012 4:07PM
- Exelixis Announces November 7th Webcast of Third Quarter 2012 Financial Results Conference Call Business Wire | Thursday October 25, 2012 4:35PM
- The biggest R&D spenders: Where innovation pays off Globe and Mail | Tuesday October 2, 2012 8:11PM
- Interim Data for Cabozantinib 40 mg Dose Cohort in Metastatic Castration-Resistant Prostate Cancer Presented at ESMO 2012 Congress Business Wire | Sunday September 30, 2012 5:45AM
- Exelixis Announces Data Presentation for GDC-0973 (XL518) Business Wire | Saturday September 29, 2012 3:57AM
- Exelixis Announces Data Presentations at ESMO 2012 Congress Business Wire | Monday September 17, 2012 6:00AM
- Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Business Wire | Thursday August 30, 2012 4:17PM
- Exelixis Provides Update on ODAC Panel for Cabozantinib Business Wire | Wednesday August 29, 2012 5:01PM
- Exelixis Announces Pricing of Concurrent Offerings of 30 Million Shares of Common Stock and $250 Million Principal Amount of Convertible Senior Subordinated Notes Business Wire | Thursday August 9, 2012 9:03AM
- Exelixis Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Debt Business Wire | Monday August 6, 2012 8:43AM
- Exelixis Announces Second Quarter 2012 Financial Results Business Wire | Thursday August 2, 2012 4:16PM
- FDA Grants Priority Review for Cabozantinib in Medullary Thyroid Cancer Business Wire | Monday July 30, 2012 6:00AM
- Exelixis Announces Initiation of Cabozantinib Investigator-Sponsored Trials in Non-Small Cell Lung Cancer and Multiple Myeloma Business Wire | Thursday July 26, 2012 6:00AM
- Exelixis Announces August 2nd Webcast of Second Quarter 2012 Financial Results Conference Call Business Wire | Thursday July 19, 2012 4:15PM
- Exelixis Announces July 13th Webcast of Presentation at the JMP Securities 7th Annual Healthcare Conference Business Wire | Tuesday July 10, 2012 6:00AM
1
2
Live Discussion of EXEL on StockTwits